AccuTheranostics
Buffalo
About AccuTheranostics
AccuTheranostics™ is a biotechnology company focused on the business of individualizing chemotherapy thereby dramatically improving outcomes for cancer patients. AccuTheranostics™ uses proprietary sophisticated technologies to provide patient-specific cancer diagnostic and prognostic information to oncologists in hospitals and oncology practices. AccuTheranostics™ is a leader in delineating the entire cellular composition of solid tumors. Specimens are shipped in AccuTheranostics’™ holding medium to our headquarters in Buffalo, New York where they undergo disaggregation, are subjected to drugs, single and in combination, and chemoresistance/sensitive profile is determined. The results will be provided within days of receiving the specimen to determine optimum treatment. AccuTheranostics™ is committed to advancing the science and practice of oncology therapeutics, with a strong emphasis on improving patient outcomes, enhancing patient quality and quantity of life.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0K
- Last round: Convertible Note (Jan 2017)
- Website: accutheranostics.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/accutheranostics-3265808 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.